Solventum Corporation

Equities

SOLV

US83444M1018

Healthcare Facilities & Services

Market Closed - Nyse 21:00:02 15/07/2024 BST 5-day change 1st Jan Change
48.22 USD -1.59% Intraday chart for Solventum Corporation -2.86% 0.00%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Morgan Stanley Adjusts Price Target on Solventum to $55 From $70, Maintains Equalweight Rating MT
Morgan Stanley Lowers Price Target on Solventum to $55 From $70, Keeps Equalweight Rating MT
Goldman Sachs Adjusts Price Target on Solventum to $48 From $54 MT
Solventum Reportedly Offers to Acquire MediWound for $400 Million CI
Solventum Corporation(NYSE:SOLV) dropped from Russell Top 200 Value Index CI
Solventum Corporation(NYSE:SOLV) dropped from Russell Top 200 Index CI
Solventum Corporation(NYSE:SOLV) added to Russell 1000 Dynamic Index CI
Solventum Corporation(NYSE:SOLV) added to Russell Midcap Index CI
Solventum Corporation(NYSE:SOLV) added to Russell Midcap Value Index CI
Solventum Corporation Introduces Denials Prevention Solution, an AI-Powered Tool, Empowering Health Systems to Help Reduce Write-Offers and Improve Top Line Revenue CI
Argus Research Initiates Solventum at Hold Rating MT
Solventum Corporation(NYSE:SOLV) added to S&P Healthcare Equipment Select Industry Index CI
Solventum Cautions Stockholders About TRC Capital's Mini-Tender Offer MT
Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target MT
Solventum Q1 Adjusted Earnings Decline, Net Sales Increase MT
Earnings Flash (SOLV) SOLVENTUM Posts Q1 Revenue $2.02B MT
Earnings Flash (SOLV) SOLVENTUM Reports Q1 EPS $2.08, vs. Street Est of $1.75 MT
Solventum Corporation Reaffirms Earnings Guidance for Its Full-Year 2024 CI
3M Updates Guidance to Reflect Solventum Spinoff Following Better-Than-Expected Quarterly Results MT
3M Q1 Adjusted Earnings Rise, Sales Decrease; Declares Dividend Payout Ratio MT
Solventum Appoints Shirley Edwards to Board of Directors CI
The latest inflation data is seriously testing investor optimism Our Logo
Morgan Stanley Initiates Solventum at Equalweight With $70 Price Target, Sees Upside Risk to 2024 Guidance But Says 'Stock Looks Cheap' MT
ANALYST RECOMMENDATIONS : Boeing, Nvidia, Spotify, Shell, Barclays... Our Logo
Wells Fargo Initiates Solventum at Equalweight Rating With $69 Price Target MT
Chart Solventum Corporation
More charts
Solventum Corporation specializes in the marketing of tools used in the medical field. The group's activity is organized around 4 product families: - medical instruments and accessories: for wound care, sterilization, surgery, etc.; - dental and orthodontic instruments and accessories: for dental care and restoration; - medical information systems: including software solutions for documentation, billing, coding, data visualization, etc. in hospital environments; - purification and filtration instruments: used in the medical, bio-pharmaceutical, agri-food and other sectors.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
48.22 USD
Average target price
58 USD
Spread / Average Target
+20.28%
Consensus
  1. Stock Market
  2. Equities
  3. SOLV Stock
  4. News Solventum Corporation
  5. Goldman Sachs Adjusts Price Target on Solventum to $48 From $54